Skip to main content

Table 3 Human Leucocyte Antigen (HLA) alleles in patients with RP with and without GD

From: Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases

 

Patients with GD (N = 5)

Patients without GD (N = 88)

P-value*

Odds ratio [95% confidence interval]

HLA-A

    

02:01

2 (20%)

19 (10.8%)

0.31

2.01 [0.29–9.78]

02:06

1 (10%)

19 (10.8%)

1.00

0.92 [0.040–6.46]

02:07**

1 (10%)

4 (2.3%)

0.24

4.70 [0.18–40.87]

11:01

1 (10%)

27 (15.3%)

1.00

0.61 [0.027–4.12]

24:02

3 (30%)

55 (31.3%)

1.00

0.94 [0.20–3.67]

26:01

0 (0%)

12 (6.8%)

1.00

0 [0.00–6.01]

26:03

1 (10%)

4 (2.3%)

0.24

4.70 [0.18–40.87]

31:01

2 (20%)

19 (10.8%)

0.31

2.06 [0.29–9.78]

33:03

0 (0%)

14 (8.0%)

1.00

0 [0.00–5.97]

HLA-B

    

07:02

0 (0%)

10 (5.7%)

1.00

0 [0.00–7.14]

15:01

2 (20%)

18 (10.2%)

0.30

2.18 [0.31–10.48]

35:01*

1 (10%)

18 (10.2%)

1.00

0.98 [0.043–6.93]

39:01

0 (0%)

7 (4.0%)

1.00

0 [0.00–11.88]

40:01

0 (0%)

11 (6.3%)

1.00

0 [0.00–6.51]

40:02

1 (10%)

12 (6.8%)

0.52

1.51 [0.065–11.84]

40:06

0 (0%)

4 (2.3%)

1.00

0 [0.00–21.06]

44:03

0 (0%)

10 (5.7%)

1.00

0 [0.00–7.14]

46:01*

1 (10%)

4 (2.3%)

0.24

4.70 [0.18–40.87]

48:01

0 (0%)

4 (2.3%)

1.00

0 [0.00–21.06]

51:01

2 (20%)

14 (8.0%)

0.21

2.87 [0.40–14.55]

52:01

1 (10%)

16 (9.1%)

1.00

1.11 [0.049–8.07]

54:01

1 (10%)

18 (10.2%)

1.00

1.00 [0.043–6.93]

55:02

0 (0%)

6 (3.4%)

1.00

0.98 [0.00–15.36]

59:01

0/10 (0%)

5/176 (2.8%)

1.00

0 [0.00–17.83]

67:01***

1/10 (10%)

5/176 (2.8%)

0.29

3.75 [0.15–36.33]

HLA-Cw

    

01:02

2 (20%)

33 (18.8%)

1.00

1.08 [0.16–5.03]

03:03

3 (30%)

26 (14.8%)

0.19

2.46 [0.52–9.91]

03:04

1 (10%)

22 (12.5%)

1.00

0.78 [0.035–5.36]

04:01

0 (10%)

9 (5.1%)

1.00

0 [0.00–8.21]

07:02

1 (10%)

28 (15.9%)

1.00

0.59 [0.026–3.94]

08:01

0 (0%)

10 (5.7%)

1.00

0 [0.00–7.14]

12:02

1 (10%)

17 (9.7%)

1.00

1.04 [0.046–7.46]

14:02

2 (20%)

11 (6.3%)

0.15

3.71 [0.51–20.24]

14:03

0 (0%)

10 (5.7%)

1.00

0 [0.00–7.14]

15:02

0 (0%)

4 (2.3%)

1.00

0 [0.00–21.06]

HLA-DRB1

    

01:01

0 (0%)

9 (5.1%)

1.00

0 [0.00–8.21]

04:03

0 (0%)

6 (3.4%)

1.00

0 [0.00–15.36]

04:05

0 (0%)

31 (17.6%)

0.22

0 [0.0–2.14]

04:06

0 (0%)

9 (5.1%)

1.00

0 [0.00–8.21]

04:07

1 (10%)

2 (1.1%)

0.15

9.38 [0.30–129.97]

04:10

0 (0%)

3 (1.7%)

1.00

0 [0.00–32.00]

08:02

1 (10%)

7 (4.0%)

0.36

2.66 [0.11–20.53]

08:03

0 (0%)

11 (6.3%)

1.00

0 [0.00–6.51]

09:01

2 (20%)

22 (12.5%)

0.62

1.74 [0.25–8.14]

11:01

0 (0%)

5 (2.8%)

1.00

0 [0.00–17.83]

12:01

2 (20%)

6 (3.4%)

0.061

6.92 [0.89–38.52]

13:02

0 (0%)

9 (5.1%)

1.00

0 [0.00–8.21]

14:03*

0 (0%)

2 (1.1%)

1.00

0 [0.00–63.42]

14:05

1 (10%)

0 (0%)

0.054

Inf [0.93–Inf]

14:54

1 (10%)

8 (4.5%)

0.40

2.32 [0.096–18.37]

15:01

1 (10%)

15 (8.5%)

0.60

1.19 [0.052–8.78]

15:02

0 (0%)

16 (9.1%)

1.00

0 [0.00–5.00]

16:02***

1 (10%)

5 (2.8%)

0.29

3.75 [0.15–36.33]

HLA-DQB1

    

03:01

2 (20%)

16 (9.1%)

0.25

2.48 [0.35–12.21]

03:02

1 (10%)

23 (13.1%)

1.00

0.74 [0.033–5.06]

03:03

3 (30%)

26 (14.8%)

0.19

2.46 [0.52–9.91]

04:01

0 (0%)

31 (17.6%)

0.22

0 [0.00–2.14]

04:02

1 (10%)

5 (2.8%)

0.29

3.75 [0.15–36.33]

05:01

0 (0%)

9 (5.1%)

1.00

0 [0.00–8.21]

05:02***

1 (10%)

12 (6.8%)

0.52

1.51 [0.065–11.85]

05:03

1 (10%)

1 (0.057%)

0.10

18.49 [0.46–751.60]

06:01

0 (0%)

27 (15.3%)

0.36

0 [0.00–2.56]

06:02

1 (10%)

15 (8.5%)

0.60

1.19 [0.052–8.78]

06:04

0 (0%)

8 (4.5%)

1.00

0 [0.00–9.71]

HLA-DPB1

    

02:01

1 (10%)

46 (26.1%)

0.46

0.32 [0.014–2.07]

02:02

2 (20%)

4 (2.3%)

0.035

10.41 [1.23–65.38]

03:01

0 (0%)

5 (2.8%)

1.00

0 [0.00–17.83]

04:01

0 (0%)

9 (5.1%)

1.00

0 [0.00–8.21]

04:02

0 (0%)

9 (5.1%)

1.00

0 [0.00–8.21]

05:01*

5 (50%)

83 (47.2%)

1.00

1.12 [0.31–4.05]

09:01

1 (10%)

11 (6.3%)

0.50

1.66 [0.071–13.38]

13:01

1 (10%)

3 (1.7%)

0.20

6.27 [0.22–63.23]

  1. The frequency of HLA-DPB1*02:02 was higher in the RP patients with GD than in the patients without GD
  2. Alleles of which frequencies in general Japanese were over 2%, alleles found among the RP patients with Graves’ disease and alleles which have been reported to be associated with autoimmune thyroiditis, relapsing polychondritis, and Bechet disease were listed
  3. P-value was obtained by Fisher’s exact test
  4. GD: Graves’ disease, Inf: infinity
  5. *Risk allele for Graves’ disease, **risk allele for Hashimoto thyroiditis, ***risk allele for relapsing polychondritis, risk allele for Bechet disease